Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDIOMAN trial of bezafibrate in Barth syndrome
2015-001382-10Phase 2Unknown
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Barth syndrome (BTHS) comparing Bezafibrate with Placebo (2 arms). Primary endpoint: Peak oxygen consumption on bicycle ergometry. Status: unknown.
02
Drugs
bezafibrate
03
Conditions
Barth syndrome (BTHS)
Beyond the preview
Go deeper on 2015-001382-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001382-10.